LOS ANGELES–(BUSINESS WIRE)– Kernel, a pioneer in neuroimaging expertise, is proud to unveil its groundbreaking Flow2 system, a significant leap ahead within the subject of purposeful neuroimaging. With Flow2, researchers and clinicians now have unprecedented entry to sturdy, fMRI-like purposeful neuroimaging in a fast and user-friendly headset, making precision neuromedicine extra accessible than ever earlier than.

Flow2 incorporates state-of-the-art time-domain purposeful near-infrared spectroscopy (TD-fNIRS) expertise together with electroencephalography (EEG). This distinctive mixture offers an exceptionally complete view of mind exercise, enabling researchers and clinicians to delve deeper into the intricate workings of the mind. TD-fNIRS measures modifications in oxygenation ranges within the mind’s cortical areas, providing high-resolution insights just like fMRI, whereas EEG captures {the electrical} mind waves, offering extra details about neural dynamics. This integration of TD-fNIRS and EEG in Flow2 coupled with the convenience of use, portability and scalability, unlocks unprecedented prospects for learning mind perform, growing sturdy biomarkers, and deeply characterizing new therapies.

“Flow2 is a game-changer in the field of neuroimaging,” stated Ryan Field, PhD, CEO of Kernel. “We now have a tool that can generate sufficient data to feed modern AI tools and draw new insights that will power the emerging field of precision neuromedicine. There are many questions that have yet to be answered because a standardized, robust, and scalable source of functional brain data was unavailable, until now.”

The Flow expertise has been validated by means of a sequence of publications demonstrating each the uncooked system efficiency and its capability to measure significant responses to psychoactive substances. Flow2 builds on these successes and has been launched into plenty of analysis settings as we begin to construct the following technology of use circumstances round highly-scalable neuroimaging.

“Our team has been working for five years to perfect the technology inside of Flow2 and it’s now ready for widespread use,” famous Field. “Our mission at Kernel is to make use of Flow2 to construct the world’s most complete portfolio of brain-based biomarkers. The sturdy and information-rich biomarkers that we’re constructing are going to allow fully new sorts of neuroscience growth to be accomplished.”

About Kernel:

Kernel is a trailblazer within the subject of neuroimaging expertise, devoted to advancing precision neuromedicine. By growing modern and accessible options, Kernel goals to construct the world’s most complete portfolio of brain-based biomarkers, revolutionizing the therapy of psychological and mind well being.

View supply model on businesswire.com: https://www.businesswire.com/news/home/20230731933400/en/